Valle Palomo

Av. Monforte De Lemos, 3-5
Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Supra-Nanoparticle Assemblies of Quantum Dots for Extracellular Immunolabeling.

Supra-Nanoparticle Assemblies of Quantum Dots for Extracellular Immunolabeling.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 07, 2026

An atlas of microtubule lattice parameters regulated through ligand binding to the microtubule-stabilizing sites.

An atlas of microtubule lattice parameters regulated through ligand binding to the microtubule-stabilizing sites.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 16, 2026

Dissecting Structural and Functional Determinants of Microtubules Stabilization through Guided Chemical Modulation.

Dissecting Structural and Functional Determinants of Microtubules Stabilization through Guided Chemical Modulation.

Journal: Journal of medicinal chemistry
Published: May 26, 2026

Lighting Up Mislocalized Proteins: Quantum Dot Probes for Multiplexed Cytoplasm-Selective Cell Profiling in Neurodegeneration.

Lighting Up Mislocalized Proteins: Quantum Dot Probes for Multiplexed Cytoplasm-Selective Cell Profiling in Neurodegeneration.

Journal: ACS sensors
Published: May 21, 2026

Illuminating microtubule functions with small molecules: past, present and future of fluorescent tubulin-binding probes.

Illuminating microtubule functions with small molecules: past, present and future of fluorescent tubulin-binding probes.

Journal: RSC chemical biology
Published: December 11, 2025

Synthesis and Early Assessment of Epothilone-Derived Fluorescent Probes for Microtubule Imaging.

Synthesis and Early Assessment of Epothilone-Derived Fluorescent Probes for Microtubule Imaging.

Journal: ChemMedChem
Published: October 22, 2025

Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.

Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.

Journal: Neuropharmacology
Published: October 04, 2025

Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders.

Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders.

Journal: Advanced drug delivery reviews
Published: November 20, 2024

Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation.

Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation.

Journal: ACS chemical neuroscience
Published: October 14, 2024

Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation.

Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 05, 2024

Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis.

Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis.

Journal: Neurobiology of disease
Published: November 26, 2023

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patients.

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patients.

Journal: Frontiers in molecular neuroscience
Published: June 23, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026